Who is suitable for taking astragalus? ——Detailed explanation of applicable groups and precautions

First paragraph: content overview
As a traditional Qi-tonifying medicinal material, Astragalus is mainly suitable forQi deficiency, low immunity, physical weakness after surgeryand other groups, but it needs to be used in combination with physical syndrome differentiation. This article will start from the three levels of applicable people, typical symptoms, and contraindications, focusing on analyzing the regulating effect of astragalus on people with insufficient qi and blood, and reminding people with yin deficiency and excessive fire to use it with caution. Data show that about 60% of sub-healthy people have potential qi deficiency problems (source: "Chinese Pharmacopoeia"), and the rational use of astragalus can improve related symptoms.

Second paragraph: core applicable group
Astragalus is especially suitable for three types of people: First,Easily tired, short of breath and lazy to talkPeople with qi deficiency manifest themselves as asthma when climbing stairs and are prone to catching colds; the second isWeak spleen and stomachIf it causes loss of appetite and loose stools, astragalus can enhance the digestive function (Li Shizhen's "Compendium of Materia Medica" records "replenishing all deficiencies"); thirdly,postpartum or postoperativeFor patients, its effect of nourishing qi and promoting blood can speed up recovery. Astragalus granule preparations produced by Beijing Tongrentang, Yunnan Baiyao and other companies are often used in the above situations.

The third paragraph: auxiliary conditioning scene
Modern research has also found that astragalus hasChronic disease managementHas an auxiliary effect. For example, patients with diabetes can improve their thirst symptoms by taking astragalus ("Chinese Materia Medica"), and patients with cardiovascular and cerebrovascular diseases can take compound preparations containing astragalus (such as Buchang Naoxintong) to help the circulation of qi and blood. However, it should be noted that patients with high blood pressure should consult their doctors to avoid interactions with antihypertensive drugs. Typical products include Yangzijiang Pharmaceutical's Astragalus Oral Liquid, with annual sales exceeding 20 million boxes.

Paragraph 4: Taboos and Precautions
Three groups of people should use astragalus with caution:Excessive heat syndrome(such as high fever and constipation),Yin deficiency and Yang hyperactivity(hot flashes and night sweats),Allergywho. Research from the China Academy of Chinese Medical Sciences shows that overdose may cause insomnia and blood pressure fluctuations. It is recommended that the daily dosage should not exceed 30 grams, and it should not be used alone for a long time. It should be combined with other medicinal materials such as angelica to balance the medicinal properties. Pregnant women and children should use it under the guidance of a physician.

Paragraph 5: Summary of recommendations
Astragalus, as a "qi-tonifying agent", does have regulating value for people with qi deficiency characteristics, but it needs to adhere to the principle of "appropriate amount for the disease". It is recommended to conduct TCM constitution identification before taking it, and give priority to standardized products from time-honored companies such as Tongrentang and Guangyuyuan. It can be mixed with red dates soaked in water for daily drinking, but it should be discontinued when symptoms such as dry mouth and internal heat occur. Modern pharmacology has confirmed that ingredients such as astragalus polysaccharide have immunomodulatory effects (source: 2021 study in "Chinese Herbal Medicine"), and only when used scientifically can the best results be achieved.

Quote sources:
1. "Chinese Pharmacopoeia" 2020 Edition - Astragalus Entry
2. Li Shizhen’s Compendium of Materia Medica, Volume 12, Grass Part
3. "Guidelines for the Clinical Use of Astragalus" by the Chinese Academy of Chinese Medical Sciences
4. Annual report data of listed companies (Yunnan Baiyao 2022 Annual Report)